Publicacións (54) Publicacións de Elena Prieto Azcárate

2024

  1. Comparison of staging using [68Ga]Ga-PSMA-11 PET/CT and histopathological results in intermediate- and high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection

    Revista Espanola de Medicina Nuclear e Imagen Molecular

2023

  1. Puesta en funcionamiento de una instalación de protonterapia: guía para preparar la documentación requerida

    Revista de Física Médica, Vol. 24, Núm. 2, pp. 13-25

  2. Sporadic Creutzfeldt–Jakob disease is associated with reorganization of metabolic connectivity in a pathological brain network

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 1035-1047

2022

  1. 11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value

    International Journal of Molecular Sciences, Vol. 23, Núm. 17

  2. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism

    Neurobiology of Disease, Vol. 167

  3. Performance evaluation of a preclinical SPECT/CT system for multi-animal and multi-isotope quantitative experiments

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. 3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 10, pp. 3048-3057

  2. A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization

    Scientific Reports, Vol. 11, Núm. 1

  3. Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma

    Physica Medica, Vol. 84, pp. 1-9

2020

  1. 18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results

    Diagnostics, Vol. 10, Núm. 6

  2. Article18 f-fdg and11 c-methionine pet/ct in newly diagnosed multiple myeloma patients: Comparison of volume-based pet biomarkers

    Cancers, Vol. 12, Núm. 4

  3. Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?

    EJNMMI Physics, Vol. 7, Núm. 1

  4. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria

    Movement Disorders, Vol. 35, Núm. 11, pp. 2009-2018

2019

  1. Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: A cross-sectional analysis from the AB255 Study

    Alzheimer's Research and Therapy, Vol. 11, Núm. 1

2018

  1. Impact on dose and image quality of a software-based scatter correction in mammography

    Acta Radiologica, Vol. 59, Núm. 6, pp. 649-656

  2. Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality

    Physica Medica, Vol. 46, pp. 134-139

2017

  1. Effective dose estimation for oncological and neurological PET/CT procedures

    EJNMMI Research, Vol. 7, Núm. 1

  2. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer

    European Radiology, Vol. 27, Núm. 8, pp. 3190-3198

  3. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury

    Journal of Translational Medicine, Vol. 15, Núm. 1

2016

  1. Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency

    Human Molecular Genetics, Vol. 25, Núm. 7, pp. 1318-1327